HOA NGUYEN: Open Payments
NPI 1942508767 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 28 payments from 8 companies in 2025. Trend: 2023 $291 · 2024 $500 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $149 |
| Novo Nordisk Inc | 7 | $133 |
| ABBVIE INC. | 6 | $122 |
| Lilly USA, LLC | 4 | $68 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: Ozempic, QULIPTA, Wegovy, MOUNJARO, VRAYLAR, TRELEGY ELLIPTA, XIFAXAN, Yeztugo.
Industry payments across NC — which companies pay providers there.
